HLA-DQA1 and peanut allergic reaction: Oral immunotherapy to food allergens is an example of controlled antigen exposure with therapeutic potential, and the relationship between HLA-DQA1*01:02 and peanut allergy provides a framework for improving our understanding of allergic sensitization and tolerance.